OBJECTIVES: We evaluated the hypothesis that plasma levels of adiponectin and leptin are independently but oppositely associated with coronary artery calcification (CAC), a measure of subclinical atherosclerosis. In addition, we assessed which biomarkers of adiposity and insulin resistance are the strongest predictors of CAC beyond traditional risk factors, metabolic syndrome, and plasma C-reactive protein (CRP). BACKGROUND: Adipokines are fat-secreted biomolecules with pleiotropic actions that converge in diabetes and cardiovascular disease. METHODS: We examined the association of plasma adipocytokines with CAC in 860 asymptomatic, nondiabetic participants in the SIRCA (Study of Inherited Risk of Coronary Atherosclerosis). RESULTS: Plasma adiponectin and leptin levels had opposite and distinct associations with adiposity, insulin resistance, and inflammation. Plasma leptin was positively (top vs. bottom quartile) associated with higher CAC after adjustment for age, gender, traditional risk factors, and Framingham risk scores (tobit regression ratio 2.42 (95% confidence interval [CI]: 1.48 to 3.95; p = 0.002) and further adjustment for metabolic syndrome and CRP (tobit regression ratio: 2.31; 95% CI: 1.36 to 3.94; p = 0.002). In contrast, adiponectin levels were not associated with CAC. Comparative analyses suggested that levels of leptin, interleukin-6, and soluble tumor necrosis factor receptor-2, as well as the homeostasis model assessment of insulin resistance (HOMA-IR) index, predicted CAC scores, but only leptin and HOMA-IR provided value beyond risk factors, metabolic syndrome, and CRP. CONCLUSIONS: In SIRCA, although both leptin and adiponectin levels were associated with metabolic and inflammatory markers, only leptin was a significant independent predictor of CAC. Of several metabolic markers, leptin and the HOMA-IR index had the most robust, independent associations with CAC.
OBJECTIVES: We evaluated the hypothesis that plasma levels of adiponectin and leptin are independently but oppositely associated with coronary artery calcification (CAC), a measure of subclinical atherosclerosis. In addition, we assessed which biomarkers of adiposity and insulin resistance are the strongest predictors of CAC beyond traditional risk factors, metabolic syndrome, and plasma C-reactive protein (CRP). BACKGROUND: Adipokines are fat-secreted biomolecules with pleiotropic actions that converge in diabetes and cardiovascular disease. METHODS: We examined the association of plasma adipocytokines with CAC in 860 asymptomatic, nondiabetic participants in the SIRCA (Study of Inherited Risk of Coronary Atherosclerosis). RESULTS: Plasma adiponectin and leptin levels had opposite and distinct associations with adiposity, insulin resistance, and inflammation. Plasma leptin was positively (top vs. bottom quartile) associated with higher CAC after adjustment for age, gender, traditional risk factors, and Framingham risk scores (tobit regression ratio 2.42 (95% confidence interval [CI]: 1.48 to 3.95; p = 0.002) and further adjustment for metabolic syndrome and CRP (tobit regression ratio: 2.31; 95% CI: 1.36 to 3.94; p = 0.002). In contrast, adiponectin levels were not associated with CAC. Comparative analyses suggested that levels of leptin, interleukin-6, and soluble tumor necrosis factor receptor-2, as well as the homeostasis model assessment of insulin resistance (HOMA-IR) index, predicted CAC scores, but only leptin and HOMA-IR provided value beyond risk factors, metabolic syndrome, and CRP. CONCLUSIONS: In SIRCA, although both leptin and adiponectin levels were associated with metabolic and inflammatory markers, only leptin was a significant independent predictor of CAC. Of several metabolic markers, leptin and the HOMA-IR index had the most robust, independent associations with CAC.
Authors: Stefan Pilz; Winfried Maerz; Gisela Weihrauch; Karine Sargsyan; Gunter Almer; Markus Nauck; Bernhard O Boehm; Bernhard R Winkelmann; Harald Mangge Journal: Clin Chim Acta Date: 2005-08-18 Impact factor: 3.786
Authors: Robert S Lindsay; Helaine E Resnick; Jianhui Zhu; Min L Tun; Barbara V Howard; Ying Zhang; Jeunliang Yeh; Lyle G Best Journal: Arterioscler Thromb Vasc Biol Date: 2005-03 Impact factor: 8.311
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: Naveed Sattar; Goya Wannamethee; Nadeem Sarwar; Julia Tchernova; Lynne Cherry; A Michael Wallace; John Danesh; Peter H Whincup Journal: Circulation Date: 2006-08-07 Impact factor: 29.690
Authors: Michael W Steffes; Myron D Gross; Duk-Hee Lee; Pamela J Schreiner; David R Jacobs Journal: Obesity (Silver Spring) Date: 2006-02 Impact factor: 5.002
Authors: Susan Cheng; Caroline S Fox; Martin G Larson; Joseph M Massaro; Elizabeth L McCabe; Abigail May Khan; Daniel Levy; Udo Hoffmann; Christopher J O'Donnell; Karen K Miller; Christopher Newton-Cheh; Andrea D Coviello; Shalender Bhasin; Ramachandran S Vasan; Thomas J Wang Journal: Am J Cardiol Date: 2011-08-01 Impact factor: 2.778
Authors: Anurag Mehta; Jaideep Patel; Mahmoud Al Rifai; Colby R Ayers; Ian J Neeland; Alka M Kanaya; Namratha Kandula; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Parag H Joshi Journal: Atherosclerosis Date: 2018-01-31 Impact factor: 5.162
Authors: Kerunne S Ketlogetswe; Wendy S Post; Xiuhong Li; Frank J Palella; Lisa P Jacobson; Joseph B Margolick; Lawrence A Kingsley; Mallory D Witt; Adrian S Dobs; Matthew J Budoff; Todd T Brown Journal: AIDS Date: 2014-03-27 Impact factor: 4.177